OGEN
Price:
$0.8516
Market Cap:
$3.55M
Oragenics, Inc. develops antibiotics for infectious diseases in the United States. The company engages in the development and commercialization of NT-CoV2-1, an intranasal vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus; and Terra CoV-2, an intramuscular vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus. The company's product candidates also comprise LPT3-04, a weight loss candidate; and SMaRT Replacement Therapy, a topical treatment to prevent dental carries. It has a license agreement with Noachis Terra Inc. for licensing of certain specified patent rights and biological materials rela...[Read more]
Industry
Biotechnology
IPO Date
2004-02-25
Stock Exchange
AMEX
Ticker
OGEN
According to Oragenics, Inc.’s latest financial reports and current stock price. The company's current ROE is -4705.41%. This represents a change of 663.78% compared to the average of -0.71% of the last 4 quarters.
The mean historical ROE of Oragenics, Inc. over the last ten years is 328.11%. The current -4705.41% ROE has changed -1534.09% with respect to the historical average. Over the past ten years (40 quarters), OGEN's ROE was at its highest in in the December 2024 quarter at 1.58%. The ROE was at its lowest in in the March 2025 quarter at -1610.16%.
Average
328.11%
Median
-108.20%
Minimum
-651.99%
Maximum
4.99%
Discovering the peaks and valleys of Oragenics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 493.64%
Maximum Annual ROE = 4.99%
Minimum Annual Increase = -864.98%
Minimum Annual ROE = -651.99%
| Year | ROE | Change |
|---|---|---|
| 2024 | 4.99% | -864.98% |
| 2023 | -651.99% | 493.64% |
| 2022 | -109.83% | 85.15% |
| 2021 | -59.32% | -62.20% |
| 2020 | -156.91% | 73.61% |
| 2019 | -90.38% | 90.37% |
| 2018 | -47.48% | -55.45% |
| 2017 | -106.57% | -54.93% |
| 2016 | -236.48% | -4.47% |
| 2015 | -247.54% | 341.93% |
The current ROE of Oragenics, Inc. (OGEN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
1.41%
5-year avg
801.91%
10-year avg
328.11%
Oragenics, Inc.’s ROE is less than AIM ImmunoTech Inc. (353.89%), greater than KALA BIO, Inc. (-2323.94%), greater than Ensysce Biosciences, Inc. (-386.70%), greater than Soligenix, Inc. (-274.80%), greater than Qualigen Therapeutics, Inc. (-72.97%), greater than Can-Fite BioPharma Ltd. (-182.93%), greater than Xenetic Biosciences, Inc. (-64.62%), greater than CNS Pharmaceuticals, Inc. (-130.12%), less than Kazia Therapeutics Limited (335.37%), greater than Titan Pharmaceuticals, Inc. (-108.55%),
| Company | ROE | Market cap |
|---|---|---|
| 353.89% | $4.19M | |
| -2323.94% | $6.77M | |
| -386.70% | $3.86M | |
| -274.80% | $16.43M | |
| -72.97% | $5.43M | |
| -182.93% | $3.65M | |
| -64.62% | $3.92M | |
| -130.12% | $3.74M | |
| 335.37% | $21.67M | |
| -108.55% | $4.44M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Oragenics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Oragenics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Oragenics, Inc.'s ROE?
How is the ROE calculated for Oragenics, Inc. (OGEN)?
What is the highest ROE for Oragenics, Inc. (OGEN)?
What is the 3-year average ROE for Oragenics, Inc. (OGEN)?
What is the 5-year average ROE for Oragenics, Inc. (OGEN)?
How does the current ROE for Oragenics, Inc. (OGEN) compare to its historical average?